Nakada H, Sawamura T, Tashiro Y
J Biochem. 1981 Jan;89(1):135-41. doi: 10.1093/oxfordjournals.jbchem.a133174.
Biosynthesis of a hepatic binding protein specific for asialoglycoproteins and its subsequent insertion into microsomal membrane were studied by using antibody monospecific for the binding protein. 125I-Labeled antibody binds much more preferentially with membrane-bound ribosomes than with free ribosomes, and nascent binding protein labeled with [3H]puromycin was detected exclusively on tightly membrane-bound ribosomes, which can be detached from the membrane by puromycin treatment in the presence of high salt buffer. When rough microsomes labeled in vivo with 14C-amino acid mixture were digested with protease, nascent binding protein was effectively protected from the digestion like nascent albumin (approximately 90%). When rough microsomes labeled in vitro with [3H]puromycin were digested with protease, the degree of protection of albumin was again approximately 90%, whereas that of the binding protein was only approximately 50%. The carbohydrate moieties of the binding protein and the bulk of glycoproteins in the microsomes labeled in vivo with [3H]glycosamine and [3H]mannose were also effectively protected from the protease digestion (approximately 90%). These results indicate that the binding protein is exclusively synthesized on the membrane-bound ribosomes and spans the microsomal membrane probably exposing the carboxyl-terminal segment on the cytoplasmic surface and the amino-terminal segment charged with carbohydrate moieties on the luminal surface, respectively.
利用对结合蛋白具有单特异性的抗体,研究了对去唾液酸糖蛋白具有特异性的肝脏结合蛋白的生物合成及其随后插入微粒体膜的过程。125I标记的抗体与膜结合核糖体的结合比与游离核糖体的结合更具选择性,并且用[3H]嘌呤霉素标记的新生结合蛋白仅在紧密结合于膜的核糖体上被检测到,在高盐缓冲液存在下,通过嘌呤霉素处理可使其从膜上脱离。当用14C氨基酸混合物在体内标记的糙面微粒体用蛋白酶消化时,新生结合蛋白像新生白蛋白一样有效地受到消化保护(约90%)。当用[3H]嘌呤霉素在体外标记的糙面微粒体用蛋白酶消化时,白蛋白的保护程度再次约为90%,而结合蛋白的保护程度仅约为50%。用[3H]葡糖胺和[3H]甘露糖在体内标记的微粒体中,结合蛋白的碳水化合物部分和大部分糖蛋白也有效地受到蛋白酶消化保护(约90%)。这些结果表明,结合蛋白仅在膜结合核糖体上合成,并且跨微粒体膜,可能分别在细胞质表面暴露羧基末端片段,在腔表面暴露带有碳水化合物部分的氨基末端片段。